Comparative evaluation of one- and two-step methods of determining factor VIIi activity
Tarasova, L.N.; Khalturina, T.I.
Laboratornoe Delo 2: 15-18
1983
ISSN/ISBN: 0023-6748 PMID: 6187972 Document Number: 212903
Document emailed within 1 workday
Related Documents
Mahasandana, C.; Suvatte, V.; Püng-amritt, P.; Tuchinda, S. 1979: Von Willebrand's disease: studies of platelet functions, factor VIII procoagulant activity (F VIII C) and factor VIII-related antigen (F VIII RAg) in three families Southeast Asian Journal of Tropical Medicine and Public Health 10(2): 243-247Naumova, G.A.; Orlova, L.D.; Andreenko, G.V. 1972: Comparative evaluation of methods of determining blood fibrinolytic activity in chronic myeloleukemia Problemy Gematologii i Perelivaniia Krovi 17(4): 44-49
Takahashi, I.; Furuta, M.; Mizuno, S.; Takamatsu, J.; Kamiya, T. 1993: Effect of substrate and diluent for factor VIIi activity in highly purified factor VIIi concentrate and patient plasma infused factor VIIi concentrate Rinsho Byori. Japanese Journal of Clinical Pathology 41(7): 825-830
Muntean, W. 1984: Purified complex of factor VIII coagulant moiety and phospholipid: high factor VIII coagulant activity in factor VIII inhibitor plasma Wiener Klinische Wochenschrift 96(22): 829-832
Teitel, J.M.; Lau, H.K.; Garvey, M.B. 2002: Discrepancies in measured factor VIIi activity in patients treated with factor VIIi concentrate of human or porcine origin Thrombosis and Haemostasis 88(1): 159-160
Brown, J.E.; Carton, C.L.; Hougie, C. 1981: The effect of naturally occurring antibodies to factor VIIi on an immunoradiometric assay for factor VIIi coagulant antigen. Observation on a cross-reacting material-positive (CRM+) hemophiliac with a factor VIIi inhibit Journal of Laboratory and Clinical Medicine 97(1): 65-71
Grimaldi, A.; Telesforo, P.; Giuliani, N.; Salino, L.; Cela, P.; Cappucci, M. 1980: Comparative evaluation of several methods of determining anti-streptolysin O Quaderni Sclavo di Diagnostica Clinica E di Laboratorio 16(3): 248-257
Antonov, M.P.; Smirnova, L.E.; Lazdin, O.A. 1982: Comparative evaluation of methods of determining the cholesterol content of bile Laboratornoe Delo 3: 31-34
Apanasenko, B.G.; Tarakanova, L.I. 1987: Comparative evaluation of methods for determining blood loss in the prehospital stage Vestnik Khirurgii Imeni I. I. Grekova 138(4): 143-145
Sitnikova, R.V.; Krylova, A.N. 1980: Comparative evaluation of spectrophotometric methods of determining the lithium content of biological fluids Laboratornoe Delo 3: 142-145
Tran, T.H.; Duckert, F. 1983: Dissociation of factor VIIi procoagulant antigen VIII:CAg and factor VIIi related antigen VIIIR:Ag by EDTA - influence of divalent cation on the binding of VIII:CAg and VIIIR:Ag Thrombosis and Haemostasis 50(2): 547-551
Shumskaia, N.I.; Mironova, L.M.; Malygina, I.G.; Sominskiĭ, A.A.; Shenfil', L.Z. 1980: Comparative evaluation of methods of determining the toxicity of rubber products in experiments with animals and cell cultures Gigiena i Sanitariia 1: 50-52
Härter, G.; Klimm, H.D.; König, B.; Koberstein, R. 1990: The evaluation of dry chemical laboratory methods. their value within the framework of step-by-step diagnosis in general medicine Fortschritte der Medizin 108(10): 203-206
Dynnik, I.B.; Dmitrieva, O.M.; Chebotar', E.V.; Okhotin, I.K.; Efimova, E.A. 1989: A comparative evaluation of methods of radiologic diagnosis in determining the functional status of the right ventricular myocardium in tetralogy of Fallot Vestnik Rentgenologii i Radiologii 1: 28-32
Rosén, S. 2001: A rebuttal: Issues with the assay of factor VIII activity in plasma and factor VII concentrates Thrombosis and Haemostasis 86(4): 1132-1133
Allain, J.P. 1972: Study of the "in vivo" activity of factor VIIi or factor IX after injection of several concentrates: practical applications Nouvelle Revue Francaise d'Hematologie 12(2): 241-249
Liebe, S. 1982: Activation of the antihemophilic globulin a (factor VIII). 2. Effect of ampholine on the course of blood coagulation and the molecular conformation of factor VIIi Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 37(4): 110-116
Brettler, D.B.; Forsberg, A.D.; Levine, P.H.; Aledort, L.M.; Hilgartner, M.W.; Kasper, C.K.; Lusher, J.M.; McMillan, C.; Roberts, H. 1989: The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experience Archives of Internal Medicine 149(6): 1381-1385
Allersma, D.P.; Smid, W.M.; van der Does, J.A.; van der Meer, J.; Briët, E. 1996: Effects of chronic factor VIII substitution on immune parameters in HIV seronegative haemophiliacs: a comparison between cryoprecipitate and factor VIII concentrate Thrombosis and Haemostasis 75(2): 261-266
Lee, C.A.; Owens, D.; Bray, G.; Giangrande, P.; Collins, P.; Hay, C.; Gomperts, E.; Schroth, P.; Barrowcliffe, T. 1999: Pharmacokinetics of recombinant factor VIIi (recombinate) using one-stage clotting and chromogenic factor VIIi assay Thrombosis and Haemostasis 82(6): 1644-1647